GEPIA analysis revealed a close correlation of PRDM1 expression with the survival of GBM patients (Fig. 6A), and a positive correlation was found between MLL4 expression and PRDM1 expression in GBM (Fig. 6B). This evidence concerns the gene KMT2D and glioblastoma.